Saxagliptin remains a cornerstone of type 2 diabetes management as a dipeptidyl peptidase-4 (DPP-4) inhibitor, marketed under brand names such as Onglyza and Kombiglyze XR. For API manufacturers, exporters, and procurement teams, identifying genuine buyers and understanding trade flows is essential for building reliable supply chains. This guide maps the global Saxagliptin buyer landscape using verified customs and trade data, regional demand insights, and practical sourcing intelligence. Understanding the Saxagliptin Trade Landscape Saxagliptin trade operates across two primary channels: bulk API (active pharmaceutical ingredient) and finished-dose formulations (tablets, fixed-dose combinations). The global market is shaped by patent expirations, regulatory approvals, and the growing demand for affordable diabetes therapies in emerging…